Autonomic Dysfunction in the Synucleinopathies

Abstract

Autonomic dysfunction is a characteristic feature in the synucleinopathies. Differences in cellular deposition and neuronal populations affected by α-synuclein aggregation influence the manifestations and severity of autonomic failure in the different synucleinopathy disorders. The Lewy body disorders (Parkinson's disease, dementia with Lewy bodies, and pure autonomic failure) have predominantly peripheral involvement, whereas multiple system atrophy chiefly manifests as central autonomic failure. Clinical and laboratory features may be useful in distinguishing the different synucleinopathies based on the pattern and severity of autonomic failure. Treatment recommendations are aimed at the underlying pathophysiology and utilize non-pharmacologic and pharmacologic approaches. This review will focus on pathophysiology, clinical manifestations, and management recommendations for autonomic failure including neurogenic orthostatic hypotension, thermoregulatory dysfunction, genitourinary dysfunction, and gastrointestinal dysfunction in the synucleinopathies.

Keywords

α-synuclein - pure autonomic failure - multiple system atrophy - dementia with Lewy bodies - Parkinson's disease - orthostatic hypotension

Publikationsverlauf

Artikel online veröffentlicht:
09. September 2020

• References

• 1 Spillantini MG, Goedert M. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 2000; 920: 16-27
• 2 Campbell BC, McLean CA, Culvenor JG. et al. The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease. J Neurochem 2001; 76 (01) 87-96
• 3 Prusiner SB, Woerman AL, Mordes DA. et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A 2015; 112 (38) E5308-E5317
• 4 Peelaerts W, Bousset L, Van der Perren A. et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 2015; 522 (7556): 340-344
• 5 Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994; 117 (Pt 2): 235-243
• 6 Cykowski MD, Coon EA, Powell SZ. et al. Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 2015; 138 (Pt 8): 2293-2309
• 7 Cersosimo MG, Benarroch EE. Central control of autonomic function and involvement in neurodegenerative disorders. Handb Clin Neurol 2013; 117: 45-57
• 8 Postuma RB, Gagnon JF, Pelletier A, Montplaisir J. Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies. Mov Disord 2013; 28 (05) 597-604
• 9 Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet Neurol 2015; 14 (01) 57-64
• 10 Savica R, Boeve BF, Mielke MM. When do α-synucleinopathies start? An epidemiological timeline: a review. JAMA Neurol 2018; 75 (04) 503-509
• 11 Tada M, Onodera O, Tada M. et al. Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol 2007; 64 (02) 256-260
• 12 Stubendorff K, Aarsland D, Minthon L, Londos E. The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia. PLoS One 2012; 7 (10) e45451
• 13 Coon EA, Sletten DM, Suarez MD. et al. Clinical features and autonomic testing predict survival in multiple system atrophy. Brain 2015; 138 (Pt 12): 3623-3631
• 14 Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001; 16 (03) 507-510
• 15 Park A, Stacy M. Non-motor symptoms in Parkinson's disease. J Neurol 2009; 256 (Suppl. 03) 293-298
• 16 Gilman S, Wenning GK, Low PA. et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71 (09) 670-676
• 17 McKeith IG, Boeve BF, Dickson DW. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 2017; 89 (01) 88-100
• 18 Thaisetthawatkul P, Boeve BF, Benarroch EE. et al. Autonomic dysfunction in dementia with Lewy bodies. Neurology 2004; 62 (10) 1804-1809
• 19 Wenning GK, Scherfler C, Granata R. et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 1999; 67 (05) 620-623
• 20 Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Neurol Sci 1996; 144 (1-2): 218-219
• 21 Schenck CH, Callies AL, Mahowald MW. Increased percentage of slow-wave sleep in REM sleep behavior disorder (RBD): a reanalysis of previously published data from a controlled study of RBD reported in SLEEP. Sleep 2003; 26 (08) 1066 , author reply 1067
• 22 Boeve BF, Silber MH, Parisi JE. et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003; 61 (01) 40-45
• 23 Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Time trends in the incidence of Parkinson disease. JAMA Neurol 2016; 73 (08) 981-989
• 24 Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol 2013; 70 (07) 859-866
• 25 Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997; 49 (05) 1284-1288
• 26 Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM. et al. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol 2015; 22 (01) 37-43
• 27 Chaudhuri KR, Rizos A, Sethi KD. Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?. J Neural Transm (Vienna) 2013; 120 (09) 1305-1320
• 28 Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM. Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 2011; 17 (10) 724-729
• 29 Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L. et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?. Mov Disord 2015; 30 (05) 639-645
• 30 Roncevic D, Palma JA, Martinez J, Goulding N, Norcliffe-Kaufmann L, Kaufmann H. Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival. J Neural Transm (Vienna) 2014; 121 (05) 507-512
• 31 Low PA, Reich SG, Jankovic J. et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 2015; 14 (07) 710-719
• 32 The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996; 46 (05) 1470
• 33 Kaufmann H, Norcliffe-Kaufmann L, Palma JA. et al. The natural history of pure autonomic failure: a U.S. prospective cohort. Ann Neurol 2017
• 34 Jain S, Goldstein DS. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 2012; 46 (03) 572-580
• 35 Kaufmann H, Goldstein DS. Autonomic dysfunction in Parkinson disease. Handb Clin Neurol 2013; 117: 259-278
• 36 Freeman R, Wieling W, Axelrod FB. et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 2011; 21 (02) 69-72
• 37 Benarroch EE. The arterial baroreflex: functional organization and involvement in neurologic disease. Neurology 2008; 71 (21) 1733-1738
• 38 Norcliffe-Kaufmann L, Kaufmann H, Palma JA. , et al; Autonomic Disorders Consortium. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 2018; 83 (03) 522-531
• 39 Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 2003; 305 (03) 800-811
• 40 Goldstein DS, Holmes C, Imrich R. Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: preliminary observations. Auton Neurosci 2009; 146 (1-2): 18-21
• 41 Goldstein DS, Holmes C, Cannon III RO, Eisenhofer G, Kopin IJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997; 336 (10) 696-702
• 42 Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 2002; 58 (08) 1247-1255
• 43 Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord 2009; 15 (07) 516-520
• 44 Goldstein DS. Sympathetic neuroimaging. Handb Clin Neurol 2013; 117: 365-370
• 45 Tipre DN, Goldstein DS. Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med 2005; 46 (11) 1775-1781
• 46 Donadio V, Cortelli P, Elam M. et al. Autonomic innervation in multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry 2010; 81 (12) 1327-1335
• 47 Benarroch EE, Smithson IL, Low PA, Parisi JE. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol 1998; 43 (02) 156-163
• 48 Coon EA, Schmeichel AM, Parisi JE, Cykowski MD, Low PA, Benarroch EE. Medullary neuronal loss is not associated with α-synuclein burden in multiple system atrophy. Mov Disord 2016; 31 (12) 1802-1809
• 49 Benarroch EE, Schmeichel AM, Low PA, Boeve BF, Sandroni P, Parisi JE. Involvement of medullary regions controlling sympathetic output in Lewy body disease. Brain 2005; 128 (Pt 2): 338-344
• 50 Senard JM, Pathak A. Neurogenic orthostatic hypotension of Parkinson's disease: what exploration for what treatment?. Rev Neurol (Paris) 2010; 166 (10) 779-784
• 51 Kaufmann H, Nahm K, Purohit D, Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 2004; 63 (06) 1093-1095
• 52 Horimoto Y, Matsumoto M, Akatsu H. et al. Autonomic dysfunctions in dementia with Lewy bodies. J Neurol 2003; 250 (05) 530-533
• 53 Singer W, Berini SE, Sandroni P. et al. Pure autonomic failure: Predictors of conversion to clinical CNS involvement. Neurology 2017; 88 (12) 1129-1136
• 54 Bleasdale-Barr KM, Mathias CJ. Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension. J R Soc Med 1998; 91 (07) 355-359
• 55 Low PA, Opfer-Gehrking TL, McPhee BR. et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995; 70 (07) 617-622
• 56 Fanciulli A, Jordan J, Biaggioni I. et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res 2018; 28 (04) 355-362
• 57 Arai K, Kato N, Kashiwado K, Hattori T. Pure autonomic failure in association with human alpha-synucleinopathy. Neurosci Lett 2000; 296 (2-3): 171-173
• 58 Kontos HA, Richardson DW, Norvell JE. Norepinephrine depletion in idiopathic orthostatic hypotension. Ann Intern Med 1975; 82 (03) 336-341
• 59 Bannister R, Crowe R, Eames R, Burnstock G. Adrenergic innervation in autonomic failure. Neurology 1981; 31 (12) 1501-1506
• 60 Fanciulli A, Göbel G, Ndayisaba JP. et al. Supine hypertension in Parkinson's disease and multiple system atrophy. Clin Auton Res 2016; 26 (02) 97-105
• 61 Berganzo K, Díez-Arrola B, Tijero B. et al. Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: are they related?. J Neurol 2013; 260 (07) 1752-1756
• 62 Umehara T, Matsuno H, Toyoda C, Oka H. Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res 2016; 26 (01) 15-21
• 63 Gibbons CH, Schmidt P, Biaggioni I. et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 2017; 264 (08) 1567-1582
• 64 Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 2006; 13 (09) 930-936
• 65 Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 2018; 33 (03) 372-390
• 66 Benarroch EE. Thermoregulation: recent concepts and remaining questions. Neurology 2007; 69 (12) 1293-1297
• 67 Langston JW, Forno LS. The hypothalamus in Parkinson disease. Ann Neurol 1978; 3 (02) 129-133
• 68 Swinn L, Schrag A, Viswanathan R, Bloem BR, Lees A, Quinn N. Sweating dysfunction in Parkinson's disease. Mov Disord 2003; 18 (12) 1459-1463
• 69 Mano Y, Nakamuro T, Takayanagi T, Mayer RF. Sweat function in Parkinson's disease. J Neurol 1994; 241 (10) 573-576
• 70 Hirayama M. Sweating dysfunctions in Parkinson's disease. J Neurol 2006; 253 (Suppl. 07) VII42-VII47
• 71 Lipp A, Sandroni P, Ahlskog JE. et al. Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol 2009; 66 (06) 742-750
• 72 Appenzeller O, Goss JE. Autonomic deficits in Parkinson's syndrome. Arch Neurol 1971; 24 (01) 50-57
• 73 Coon EA, Fealey RD, Sletten DM. et al. Anhidrosis in multiple system atrophy involves pre- and postganglionic sudomotor dysfunction. Mov Disord 2017; 32 (03) 397-404
• 74 Coon EA, Fealey RD, Benarroch EE, Sandroni P, Low PA, Singer W. Purple hands in multiple system atrophy: global anhidrosis with preserved acral sweating. Neurology 2016; 86 (24) 2317
• 75 Coon EA, Fealey RD, Sletten DM. et al. Anhidrosis in multiple system atrophy involves pre- and postganglionic sudomotor dysfunction. Mov Disord 2017; 32 (03) 397-404
• 76 Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson's disease. Neurology 1986; 36 (01) 73-75
• 77 Benarroch EE. Neural control of feeding behavior: overview and clinical correlations. Neurology 2010; 74 (20) 1643-1650
• 78 Sakakibara R, Ito T, Uchiyama T. et al. Lower urinary tract function in dementia of Lewy body type. J Neurol Neurosurg Psychiatry 2005; 76 (05) 729-732
• 79 McKay JH, Cheshire WP. First symptoms in multiple system atrophy. Clin Auton Res 2018; 28 (02) 215-221
• 80 Benarroch EE, Schmeichel AM. Depletion of corticotrophin-releasing factor neurons in the pontine micturition area in multiple system atrophy. Ann Neurol 2001; 50 (05) 640-645
• 81 Gelpi E, Navarro-Otano J, Tolosa E. et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 2014; 29 (08) 1010-1018
• 82 McDonald C, Winge K, Burn DJ. Lower urinary tract symptoms in Parkinson's disease: prevalence, aetiology and management. Parkinsonism Relat Disord 2017; 35: 8-16
• 83 Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res 2003; 15 (04) 293-298
• 84 Özcan T, Benli E, Özer F, Demir EY, Kaya Y, Ayyıldız A. The association between symptoms of sexual dysfunction and age at onset in Parkinson's disease. Clin Auton Res 2016; 26 (03) 205-209
• 85 Coon EA, Nelson RM, Sletten DM. et al. Sex and gender influence symptom manifestation and survival in multiple system atrophy. Auton Neurosci 2019; 219: 49-52
• 86 Bronner G, Vodušek DB. Management of sexual dysfunction in Parkinson's disease. Ther Adv Neurol Disorder 2011; 4 (06) 375-383
• 87 Travagli RA, Hermann GE, Browning KN, Rogers RC. Brainstem circuits regulating gastric function. Annu Rev Physiol 2006; 68: 279-305
• 88 Benarroch EE. Enteric nervous system: functional organization and neurologic implications. Neurology 2007; 69 (20) 1953-1957
• 89 Suttrup I, Warnecke T. Dysphagia in Parkinson's disease. Dysphagia 2016; 31 (01) 24-32
• 90 Bagheri H, Damase-Michel C, Lapeyre-Mestre M. et al. A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol 1999; 22 (04) 213-215
• 91 Bird MR, Woodward MC, Gibson EM, Phyland DJ, Fonda D. Asymptomatic swallowing disorders in elderly patients with Parkinson's disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients. Age Ageing 1994; 23 (03) 251-254
• 92 Suttrup I, Suttrup J, Suntrup-Krueger S. et al. Esophageal dysfunction in different stages of Parkinson's disease. Neurogastroenterol Motil 2017; 29 (01) 29
• 93 Su A, Gandhy R, Barlow C, Triadafilopoulos G. Clinical and manometric characteristics of patients with Parkinson's disease and esophageal symptoms. Dis Esophagus 2017; 30 (04) 1-6
• 94 Bestetti A, Capozza A, Lacerenza M, Manfredi L, Mancini F. Delayed gastric emptying in advanced Parkinson disease: correlation with therapeutic doses. Clin Nucl Med 2017; 42 (02) 83-87
• 95 Bharucha AE. Constipation. Best Pract Res Clin Gastroenterol 2007; 21 (04) 709-731
• 96 Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R. Parkinson disease: the enteric nervous system spills its guts. Neurology 2011; 77 (19) 1761-1767
• 97 Abbott RD, Ross GW, Petrovitch H. et al. Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 2007; 22 (11) 1581-1586
• 98 Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 2006; 66 (03) 378-383
• 99 Arbouw ME, Movig KL, Koopmann M. et al. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology 2010; 74 (15) 1203-1207
• 100 Srivanitchapoom P, Pandey S, Hallett M. Drooling in Parkinson's disease: a review. Parkinsonism Relat Disord 2014; 20 (11) 1109-1118
• 101 De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT. Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol 2017; 74 (08) 970-976
• 102 Wenning GK, Geser F, Krismer F. , et al; European Multiple System Atrophy Study Group. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 2013; 12 (03) 264-274